Eaton Vance Management Novartis Ag Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Novartis Ag stock. As of the latest transaction made, Eaton Vance Management holds 293,532 shares of NVS stock, worth $33.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
293,532
Previous 296,040
0.85%
Holding current value
$33.8 Million
Previous $25 Million
10.84%
% of portfolio
0.03%
Previous 0.04%
Shares
23 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.4 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$853 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$852 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$684 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $247B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...